Experts on the Ground: New Data and Practical Clinical Integration of Therapies Approved for IgAN
Pietro A. Canetta, MD
PeerWhat Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma
Jeffrey S. Weber, MD, PhD
PeerManesh R. Patel, MD
PeerManaging Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
Mario E. Lacouture, MD
PeerACC 2024: VOYAGER PAD Part 2
Marc P. Bonaca, MD, MPH
Peer